Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Changes in symptoms after Qa-2 siRNA injection into BD mice

From: The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex

siRNA

Deteriorated number/

total number

Qa-2 siRNA

3/6

Leader peptide siRNA

1/6

Glucose

0/7

  1. The symptoms of BD mice deteriorated following treatment with Qa-2 siRNA. Qa-2 siRNA was intravenously injected into BD mice four times with a three day interval between injections. Deterioration occurred in three of six BD mice.